Abstract
Leukemia inhibitory factor [LIF] is a glycoprotein that is able to induce the differentiation of M1 myeloid leukemic cells and prevent the differentiation of murine embryonic stem [ES] cells. This report presents a simple method for the production and purification of large amounts of recombinant murine and human LIF in Escherichia coli. LIF is expressed initially as a fusion product with glutathione Stransferase, separated by a thrombin cleavage site. The fusion product can be rapidly purified on a glutathione-agarose affinity matrix and fully biologically active LIF released from the matrix by cleavage with thrombin. In this form LIF is suitable for many in vitro cell culture uses and in particular for ES cell culture. Further purification to homogeneity of thrombin-released LIF can be achieved by a single fractionation by reversed-phase high performance liquid chromatography; the purified product contains no detectable bacterial endotoxin. Evidence is presented that the intact fusion product has little or no biological activity but biologically active LIF is released by endogenous proteolytic cleavage.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gearing, D.P., Gough, N.M., King, J.A., Hilton, D.J., Nicola, N.A., Simpson, R.J., Nice, E.C., Kelso, A., and Metcalf, D. 1987. Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J. 6:3995–4002.
Gough, N.M., Gearing, D.P., King, J.A., Willson, T.A., Hilton, D.J., Nicola, N.A., and Metcalf, D. 1988. Molecular cloning and expression of the human gene homologous to murine myeloid leukaemia inhibitory factor (LIF). Proc. Natl. Acad. Sci. USA 85:2623–2627.
Hilton, D.J., Nicola, N.A., and Metcalf, D. 1988. Purification of a murine leukemia inhibitory factor from Krebs Ascites cells. Anal. Biochem. 173:359–367.
Hilton, D.J., Nicola, N.A. and Metcalf, D. 1988. Specific binding of murine leukemia inhibitory factor to normal and leukemic monocytic cells. Proc. Natl. Acad. Sci. USA 85:5971–5975.
Metcalf, D., Hilton, D.J., and Nicola, N.A. 1988. Clonal analysis of the actions of the murine leukemia inhibitory factor on leukemic and normal murine hemopoietic cells. Leukemia 2:216–221.
Gearing, D.P., King, J.A., and Gough, N.M. 1988. Complete sequence of murine myeloid leukaemia inhibitory factor. Nucl. Acids. Res. 16:9857.
Simpson, R.J., Hilton, D.J., Nice, E.C., Rubira, M.R., Metcalf, D., Gearing, D.P., Gough, N.M. and Nicola, N.A. 1988. Structural characterization of a murine myeloid leukaemia inhibitory factor (LIF). Eur. J. Biochem. 175:541–547.
Maekawa, T. and Metcalf, D. 1989. Clonal suppression of HL60 and U937 cells by recombinant human leukemia inhibitory factor in combination with GM-CSF or G-CSF. Leukemia 3:270–276.
Tomida, M., Yamamoto-Yamaguchi, Y. and Hozumi, M. 1984. Purification of a factor inducing differentiation of mouse myeloid leukemic M1 cells from conditioned medium of mouse fibroblast L929 cells. J. Biol. Chem. 259:10978–10982.
Williams, R.L., Hilton, D.J., Pease, S., Willson, T.A., Stewart, C.L., Gearing, D.P., Wagner, E.F., Metcalf, D., Nicola, N.A., and Gough, N.M. 1988. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336:684–687.
Smith, A.G., Heath, J.K., Donaldson, D.D., Wong, G.G., Moreau, J., Stahl, M. and Rogers, D. 1988. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336:688–690.
Thomas, K.R. and Capecchi, M.R. 1987. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51:503–512.
Metcalf, D. and Gearing, D.P. 1989. A fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor (LIF). Proc. Natl. Acad. Sci. USA 86:5948–5952.
Smith, D.B. and Johnson, K.S. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31–40.
Smith, D.B., Davern, K.M., Board, P.G., Tiu, W.U., Garcia, E.G. and Mitchell, G.F. 1986. Mr 26000 antigen of Schistosoma japonicum recognized by resistant WEHI 129/J mice is a parasite glutathione S-transferase. Proc. Natl. Acad. Sci. USA 83:8703–8707.
Smith, D.B., Davern, K.M., Board, P.G., Tiu, W.U., Garcia, E.G. and Mitchell, G.F. 1987. Mr 26000 antigen of Schistosoma japonicum recognized by resistant WEHI 129/J mice is a parasite glutathione S-transferase. Proc. Natl. Acad. Sci. USA 84:6541.
Smith, D.B., Rubira, M.R., Simpson, R.J., Davern, K.M., Tiu, W.U., Board, P.G., and Mitchell, G.F. 1988. Expression of an enzymatically-active parasite molecule in Escherichia coli: Schistosoma japonicum glutathione S-transferase. Mol. Biochem. Parasitol. 27:249–256.
Yanisch-Perron, C., Vieira, J. and Messing, J. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103–119.
Maniatis, T., Fritsch, E.F. and Sambrook, J. 1982. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685.
Morrisey, J.H. 1981. Silver stain for proteins in polyacrylamide gels: A modified procedure with enhanced uniform sensitivity. Anal. Biochem. 117:307–310.
Bernstine, E.G., Hooper, M.L., Grandchamp, S. and Ephrussi, B. 1973. Alkaline phosphatase activity in mouse teratoma. Proc. Natl. Acad. Sci. USA 70:3899–3903.
Burstone, M.S. 1962. Enzyme Histochemistry and Its Application in the Study of Neoplasias, p. 88–113. Academic Press, New York.
Doetschman, T.C., Eistetter, H., Katz, M., Schmidt, W. and Kemler, R. 1985. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87:27–45.
Smith, A.G., and Hooper, M.L. 1987. Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev. Biol. 121:1–9.
Hopp, T.P., Prickett, K.S., Price, V.L., Libby, R.T., March, C.J., Cerretti, D.P., Urdal, D.L., and Conlon, P.J. 1988. A short polypeptide marker sequence useful for recombinant protein identification and purification. Bio Technology 6:1204–1210.
Leutz, A., Damm, K., Sterneck, E., Kowenz, E., Ness, S., Frank, R., Gausepohl, H., Pan, Y-C.E., Smart, J., Hayman, M., Graf, T. 1989. Molecular cloning of the chicken myelomonocytic growth factor (cMGF) reveals relationship to interleukin 6 and granulocyte colony stimulating factor. EMBO J 8:175–181.
Nagai, K. and Thogerson, H.C. 1987. Synthesis and sequence specific proteolysis of hybrid proteins produced by Escherichia coli. Methods Enzymol. 153:461–481.
Levin, J., Tomasulo, P.A. and Oser, R.S. 1970. Detection of endotoxin human blood and demonstration of an inhibitor. J. Lab. Clin. Med. 75:903.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gearing, D., Nicola, N., Metcalf, D. et al. Production of Leukemia Inhibitory Factor in Escherichia coli by a Novel Procedure and Its Use in Maintaining Embryonic Stem Cells in Culture. Nat Biotechnol 7, 1157–1161 (1989). https://doi.org/10.1038/nbt1189-1157
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt1189-1157